Everyone Ages 18 and Older Should Get a Booster Shot IF YOU RECEIVED Pfizer-BioNTech or Moderna Who should get a booster: Everyone 18 years or older When to get a booster: At least 6 months after completing your primary COVID-19 vaccination series. Which booster should you get? Any of the […]
Read More
A Medscape poll on clinicians’ confidence surrounding the COVID-19 vaccine for kids ages 5-11 showed significant hesitancy. Among physician respondents who have children in that age group, 30% said they would not want their children to be vaccinated; 9% were unsure. For nurses/advanced practice registered nurses (APRNs), more (45%) said they did […]
Read More
Pfizer announced on Monday that its COVID-19 vaccine provided long-term protection against the virus in a late-stage clinical trial among adolescents ages 12-15. A two-dose series was 100% effective against COVID-19, which was measured between 7 days and 4 months after the second dose. “As the global health community works […]
Read More
Pfizer firmó un acuerdo de licencia voluntaria, por medio del cual se establece que cederá a 95 países, la patente de su pastilla contra el Covid-19, una vez que ésta haya recibido la autorización. Este martes 16 de noviembre, Pfizer y la organización Medicines Patent Pool (MPP), hicieron el anuncio de forma conjunta […]
Read More
Pfizer Inc dijo este martes que está solicitando la autorización en Estados Unidos para su píldora antiviral experimental contra el Covid-19, que redujo en un 89% la posibilidad de hospitalización o muerte de adultos con riesgo de enfermedad grave en una prueba clínica. Pfizer afirmó que completó la presentación de […]
Read More
Pfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world. On Tuesday, the company said it would give a license for the pill to the Medicines Patent Pool, a U.N.-backed group based in Geneva, […]
Read More
Background Before 2020, mental disorders were leading causes of the global health-related burden, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19 pandemic has created an environment where many determinants of poor mental health are exacerbated. The need for up-to-date information on the […]
Read More
Opening a new chapter in the treatment of COVID-19—one borrowed from successfully tackling the AIDS virus—the drug behemoth Pfizer today reported upbeat results for a 5-day pill regimen to treat early infections with SARS-CoV-2. In a trial that an outside monitoring group halted early because the treatment appeared so promising, […]
Read More
Créditos: Comité científico Covid
Read More
El comité de expertos de la FDA vota a favor de autorizar la vacuna de pfizer contra COVID-19 para niños de 5-11 años. https://m.facebook.com/story.php?story_fbid=425312435708928&id=100046905255251&sfnsn=scwspwa Créditos: Comité científico Covid
Read More